These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36209630)

  • 1. Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels.
    Akman D; Denzinger K; Huang S; Lee JT; Nafie JW; Wolber G; Zamponi GW; Armstrong DW; Gündüz MG
    Eur J Med Chem; 2022 Dec; 244():114787. PubMed ID: 36209630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
    Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
    Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.
    Bladen C; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
    Pflugers Arch; 2014 Jul; 466(7):1355-63. PubMed ID: 24149495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels.
    Aygün Cevher H; Schaller D; Gandini MA; Kaplan O; Gambeta E; Zhang FX; Çelebier M; Tahir MN; Zamponi GW; Wolber G; Gündüz MG
    Bioorg Chem; 2019 Oct; 91():103187. PubMed ID: 31419643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
    Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
    Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular simulations study of novel 1,4-dihydropyridines derivatives with a high selectivity for Cav3.1 calcium channel.
    Liu X; Yu H; Zhao X; Huang XR
    Protein Sci; 2015 Nov; 24(11):1737-47. PubMed ID: 26256672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers.
    Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
    Bioorg Chem; 2019 Jul; 88():102915. PubMed ID: 31005784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities.
    Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
    Bioorg Chem; 2019 Mar; 83():354-366. PubMed ID: 30408648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
    Bladen C; Gadotti VM; Gündüz MG; Berger ND; Şimşek R; Şafak C; Zamponi GW
    Pflugers Arch; 2015 Jun; 467(6):1237-47. PubMed ID: 24990197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.
    Drígelová M; Tarabová B; Duburs G; Lacinová L
    Can J Physiol Pharmacol; 2009 Nov; 87(11):923-32. PubMed ID: 19935900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
    Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
    J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.
    Kang S; Cooper G; Dunne SF; Luan CH; James Surmeier D; Silverman RB
    Bioorg Med Chem; 2013 Jul; 21(14):4365-73. PubMed ID: 23688558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.
    Ogihara T; Kano T; Kakinuma C
    Arzneimittelforschung; 2009; 59(6):283-8. PubMed ID: 19634509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorinated dihydropyridines as candidates to block L-type voltage-dependent calcium channels.
    Menezes Spadeto JP; Freitas MP; Cormanich RA
    J Biomol Struct Dyn; 2022; 40(24):13456-13471. PubMed ID: 34720037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective calcium channel blockers on ions' permeation through the human Cav1.2 ion channel: A computational study.
    Mosa FES; C S; Feng T; Barakat K
    J Mol Graph Model; 2021 Jan; 102():107776. PubMed ID: 33137694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion.
    Enyeart JJ; Enyeart JA
    Am J Physiol Cell Physiol; 2015 Jun; 308(11):C899-918. PubMed ID: 25788571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation.
    Koschak A; Reimer D; Walter D; Hoda JC; Heinzle T; Grabner M; Striessnig J
    J Neurosci; 2003 Jul; 23(14):6041-9. PubMed ID: 12853422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
    Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
    Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.